Centene is in all the big Medicare markets, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer, who interviewed CEO Michael Niedorff on Friday's edition of CNBC's "Mad Money."
Jim Cramer and our other experts look at President Trump, the new tariffs on China, Walgreens stock, and Etsy.
While the CREATES ACT passed out of committee in the Senate, Senator Orrin Hatch, who helped pave the way for generic drugs in the U.S,,voted against the measure.
The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.
The biopharmaceutical companies saw their stocks drop amid fallout of failed Alzheimer's drug trials.
More research is needed, but medical experts agree that cannabis plants have immense potential to slow opioid drug overdoses, which claim 115 lives every day in the U.S.
Cigna CEO David Cordani is game on in trying to shape the future of healthcare. He talks with TheStreet on where he thinks things are headed.
The Right to Try Act has been championed as a way to give seriously ill patients more options, but the author of bill says it is about getting FDA out of 'people's lives.'
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.